Anavex Life Sciences (AVXL) is scheduled to report Q2 earnings on July 10, 2026. Analysts estimate EPS of $-0.07 and quarterly revenue of N/A.
In the most recent quarter (Q1), Anavex Life Sciences reported EPS of $-0.06, beating estimates of $-0.11 by 0.45%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Anavex Life Sciences has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Anavex Life Sciences has averaged an EPS surprise of 0.24% and a revenue surprise of 0.00%.
Analyze the earnings history of Anavex Life Sciences using advanced sorting and filters.
The chart below shows Anavex Life Sciences's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Anavex Life Sciences's reported revenue compared to analyst estimates over recent quarters.
Anavex Life Sciences (AVXL) is scheduled to report earnings on August 11, 2026. The last reported earnings were for reported on February 9, 2026 for Q1.
The Actual EPS was $-0.06, which beat the estimate of $-0.11.
The Actual Revenue was $0.00, which hit the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-02-09 | $-0.06 | $-0.11 | 45.5 % |
| Q4 | 2025-11-25 | $-0.11 | $-0.14 | 21.4 % |
| Q3 | 2025-08-12 | $-0.16 | $-0.14 | -14.3 % |
| Q2 | 2025-05-13 | $-0.13 | $-0.15 | 13.3 % |